Found: 4
Select item for more details and to access through your institution.
A Flare Risk Index Informed by Select Immune Mediators in Systemic Lupus Erythematosus.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 5, p. 723, doi. 10.1002/art.42389
- By:
- Publication type:
- Article
Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patients.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1224702
- By:
- Publication type:
- Article
Immune checkpoint inhibitor-induced inflammatory arthritis: a novel clinical entity with striking similarities to seronegative rheumatoid arthritis.
- Published in:
- Clinical Rheumatology, 2020, v. 39, n. 12, p. 3631, doi. 10.1007/s10067-020-05162-9
- By:
- Publication type:
- Article
Optimization of flare management in patients with rheumatoid arthritis: results of a randomized controlled trial.
- Published in:
- Clinical Rheumatology, 2019, v. 38, n. 11, p. 3025, doi. 10.1007/s10067-019-04664-5
- By:
- Publication type:
- Article